Get the Stockscreener App
339.21
3.09%
-11.85
Beone Medicines Ltd Adr stock is traded at $339.21, with a volume of 28,259.
It is down -3.09% in the last 24 hours and up +6.63% over the past month.
Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeOne is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeOne runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeOne's revenue.
See More
Previous Close:
$351.06
Open:
$343.9
24h Volume:
28,259
Relative Volume:
0.10
Market Cap:
$37.54B
Revenue:
$4.98B
Net Income/Loss:
$69.59M
P/E Ratio:
652.70
EPS:
0.5197
Net Cash Flow:
$525.67M
1W Performance:
+1.90%
1M Performance:
+6.63%
6M Performance:
+34.93%
1Y Performance:
+69.26%
1-Day Range:
$337.25
$343.90
1-Week Range:
$317.97
$352.46
52-Week Range:
$196.45
$385.22
Beone Medicines Ltd Adr Stock (ONC) Company Profile
Name
Beone Medicines Ltd Adr
Sector
Industry
Phone
41-616851900
Address
C/O BEONE MEDICINES I GMBH, BASEL
Compare ONC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ONC
Beone Medicines Ltd Adr
|
339.20 | 38.85B | 4.98B | 69.59M | 525.67M | 0.5197 |
|
VRTX
Vertex Pharmaceuticals Inc
|
454.57 | 115.36B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
763.96 | 79.76B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
809.65 | 50.16B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
371.59 | 48.88B | 3.21B | 43.57M | 221.36M | 0.2405 |
Beone Medicines Ltd Adr Stock (ONC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-24-25 | Initiated | Truist | Buy |
| Sep-18-25 | Initiated | Barclays | Overweight |
| Apr-07-25 | Initiated | RBC Capital Mkts | Outperform |
| Mar-03-25 | Upgrade | BofA Securities | Neutral → Buy |
| Dec-03-24 | Resumed | Morgan Stanley | Overweight |
| Sep-18-24 | Initiated | JMP Securities | Mkt Outperform |
| Feb-06-24 | Resumed | JP Morgan | Overweight |
| Sep-12-23 | Initiated | Macquarie | Outperform |
| Aug-17-23 | Initiated | Jefferies | Buy |
| Jul-17-23 | Initiated | Citigroup | Buy |
| Jun-30-23 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Jan-12-23 | Initiated | Daiwa Securities | Buy |
| Oct-13-22 | Upgrade | Guggenheim | Neutral → Buy |
| Oct-13-22 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Aug-09-22 | Resumed | JP Morgan | Overweight |
| Mar-17-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Feb-07-22 | Initiated | Deutsche Bank | Buy |
| Oct-12-21 | Initiated | Bernstein | Outperform |
| Oct-06-21 | Upgrade | CLSA | Underperform → Buy |
| Mar-08-21 | Initiated | China Renaissance | Buy |
| Mar-01-21 | Downgrade | CLSA | Outperform → Underperform |
| Nov-09-20 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Nov-06-20 | Downgrade | Maxim Group | Buy → Hold |
| Nov-06-20 | Downgrade | Piper Sandler | Neutral → Underweight |
View All
Beone Medicines Ltd Adr Stock (ONC) Latest News
Chan Henry Lee Sells 664 Shares of BeOne Medicines (NASDAQ:ONC) Stock - Defense World
JGP Global Gestao de Recursos Ltda. Decreases Stock Position in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
1,608 Shares in BeOne Medicines Ltd. – Sponsored ADR $ONC Purchased by Clear Harbor Asset Management LLC - Defense World
BeOne Medicines (NASDAQ:ONC) SVP Chan Henry Lee Sells 664 Shares - MarketBeat
Is the Options Market Predicting a Spike in BeOne Medicines Stock? - Yahoo Finance
Ziihera® (zanidatamab-hrii) Combinations Achieve Unprecedented Results in First-Line HER2+ Locally Advanced or Metastatic GEA including more than Two Years Median Overall Survival Benefit - GlobeNewswire Inc.
BeOne Medicines Ltd. – Sponsored ADR (NASDAQ:ONC) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
BeOne Medicines Ltd.Sponsored ADR (NASDAQ:ONC) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Voya Investment Management LLC Raises Holdings in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
BeOne Medicines Granted U.S. FDA Fast Track Designation for BGB-B2033 as Treatment for Hepatocellular Carcinoma - Chartmill
John Oyler Sells 75,631 Shares of BeOne Medicines (NASDAQ:ONC) Stock - MarketBeat
BeOne Medicines (NASDAQ:ONC) CEO John Oyler Sells 24,369 Shares - MarketBeat
BeOne Medicines (NASDAQ:ONC) Shares Gap Down After Insider Selling - Defense World
BeOne Medicines (NASDAQ:ONC) Shares Gap Down Following Insider Selling - MarketBeat
LMR Partners LLP Acquires New Position in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
China Universal Asset Management Co. Ltd. Makes New Investment in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
BeOne Medicines (NASDAQ:ONC) SVP Sells $107,900.00 in Stock - MarketBeat
35,910 Shares in BeOne Medicines Ltd. – Sponsored ADR $ONC Purchased by Axa S.A. - Defense World
Bellevue Group AG Makes New $9.37 Million Investment in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
35,910 Shares in BeOne Medicines Ltd.Sponsored ADR $ONC Purchased by Axa S.A. - MarketBeat
OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC Purchases Shares of 9,377 BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
12,338 Shares in BeOne Medicines Ltd. – Sponsored ADR $ONC Purchased by American Century Companies Inc. - Defense World
8,037 Shares in BeOne Medicines Ltd.Sponsored ADR $ONC Acquired by Guggenheim Capital LLC - MarketBeat
First Trust Advisors LP Makes New Investment in BeOne Medicines Ltd. – Sponsored ADR $ONC - Defense World
First Trust Advisors LP Makes New Investment in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
12,338 Shares in BeOne Medicines Ltd.Sponsored ADR $ONC Purchased by American Century Companies Inc. - MarketBeat
Temasek Holdings Private Ltd Acquires New Position in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Nan Fung Group Holdings Ltd Makes New $3.81 Million Investment in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Jump Financial LLC Invests $17.02 Million in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Russell Investments Group Ltd. Acquires Shares of 13,603 BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
7,707 Shares in BeOne Medicines Ltd.Sponsored ADR $ONC Bought by Tema Etfs LLC - MarketBeat
Walleye Capital LLC Purchases Shares of 36,645 BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
467,590 Shares in BeOne Medicines Ltd.Sponsored ADR $ONC Bought by Marshall Wace LLP - MarketBeat
3,330 Shares in BeOne Medicines Ltd.Sponsored ADR $ONC Bought by Qtron Investments LLC - MarketBeat
Baird Financial Group Inc. Invests $82.90 Million in BeOne Medicines Ltd. – Sponsored ADR $ONC - Defense World
Hsbc Holdings PLC Invests $4.99 Million in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Geode Capital Management LLC Acquires New Holdings in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
BeOne Medicines Ltd. – Sponsored ADR (NASDAQ:ONC) Receives Average Rating of “Moderate Buy” from Analysts - Defense World
Baird Financial Group Inc. Invests $82.90 Million in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Mackenzie Financial Corp Purchases Shares of 41,328 BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Corazon (Corsee) Sanders Sells 2,627 Shares of BeOne Medicines (NASDAQ:ONC) Stock - Defense World
Franklin Resources Inc. Purchases Shares of 16,254 BeOne Medicines Ltd. – Sponsored ADR $ONC - Defense World
Franklin Resources Inc. Purchases Shares of 16,254 BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
BeOne Medicines (NASDAQ:ONC) Director Corazon (Corsee) Sanders Sells 2,627 Shares - MarketBeat
Virtus Investment Advisers LLC Invests $389,000 in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Legal & General Group Plc Buys Shares of 57,243 BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Jefferies Financial Group Inc. Purchases Shares of 2,900 BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
PNC Financial Services Group Inc. Makes New $228,000 Investment in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
5,981 Shares in BeOne Medicines Ltd.Sponsored ADR $ONC Purchased by Creative Planning - MarketBeat
16,300 Shares in BeOne Medicines Ltd.Sponsored ADR $ONC Acquired by Pinpoint Asset Management Singapore Pte. Ltd. - MarketBeat
Edmond DE Rothschild Holding S.A. Invests $9.93 Million in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Beone Medicines Ltd Adr Stock (ONC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Beone Medicines Ltd Adr Stock (ONC) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Lee Chan Henry | SVP, General Counsel |
Jan 07 '26 |
Sale |
331.76 |
664 |
220,289 |
0 |
| OYLER JOHN | Chief Executive Officer |
Dec 15 '25 |
Sale |
307.79 |
75,631 |
23,278,679 |
24,369 |
| OYLER JOHN | Chief Executive Officer |
Dec 16 '25 |
Sale |
302.87 |
24,369 |
7,380,739 |
0 |
0.57%
1.37%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):